ask="2.80"
ask_size="13100"
average_daily_volume="236545"
bid="1.00"
bid_size="100"
book_value="5.66"
change="-0.10"
change_from_200_day_moving_average="-0.71"
change_from_50_day_moving_average="-0.24"
change_from_52_week_high="-3.66"
change_From_52_week_low="0.00"
change_in_percent="-3.64%"
close="2.65"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.27"
ebitda="-47.17M"
eps_estimate_current_year="-2.41"
eps_estimate_next_quarter="-0.31"
eps_estimate_next_year="-1.28"
ex_dividend_date="N/A"
float_shares="28497000"
high="2.75"
high_52_weeks="6.31"
last_trade_date="2/28/2017"
last_trade_price="2.65"
last_trade_size="7526"
last_trade_time="4:00pm"
low="2.65"
low_52_weeks="2.65"
market_capitalization="110.55M"
moving_average_200_day="3.36"
moving_average_50_day="2.89"
name="Adverum Biotechnologies
Inc."
notes="N/A"
one_year_target_price="7.00"
open="2.70"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-21.01%"
percent_change_from_50_day_moving_average="-8.39%"
percent_change_from_52_week_high="-58.00%"
percent_change_from_52_week_low="+0.00%"
previous_close="2.75"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.49"
price_per_sales="59.54"
revenue="1.93M"
shares_outstanding="41718000"
short_ratio="2.26"
stock_exchange="NGM"
symbol="ADVM"
volume="173801"
weeks_range_52="2.65 - 6.31"
